Ilaris (canakinumab) is a prescription drug that’s used to treat certain conditions such as Still disease. Ilaris comes as a liquid solution that a healthcare professional will give as an injection ...

Ilaris (canakinumab) can cause side effects that range from mild to serious. More common side effects include weight gain and the common cold. If side effects from Ilaris become difficult to tolerate, ...

Novartis receives EU approval for Ilaris® in patients suffering acute gouty arthritis attacks who cannot gain relief from current treatments Ilaris® is the first biologic approved in the EU for ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Novartis’ Ilaris injection for the treatment of active and adult-onset Still’s disease, ...

Jazz Pharmaceuticals and PharmaMar’s Zepzelca (lurbinectedin) has been granted accelerated approval for adult patients with metastatic small cell lung cancer (SCLC) whose disease has progressed during ...

The U.S. Food and Drug Administration on Tuesday said it approved Novartis AG's Ilaris injection to treat Still's disease, including Adult-Onset Still's disease. Ilaris, or canakinumab, had been ...

New biological therapy Ilaris® approved in US to treat children and adults with CAPS, a serious life-long auto-inflammatory disease Phase III data show rapid and sustained remission in more than 90% ...

EAST HANOVER, N.J. — The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday. Novartis ...